Greffex has established a leading position in pandemic and bioterrorism vaccine delivery
Greffex has developed a broad strategy to protect our intellectual property. All property pertaining to our core technologies are owned by Greffex, and is the subject of patents and patent applications in various jurisdictions, including Europe, United States, and Canada.
Greffex has established a leading position in pandemic and bioterrorism vaccine delivery and is protecting this position with a comprehensive intellectual property portfolio. Greffex’s patent filings aim to prevent duplication of its technologies and platforms.